SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-17-002766
Filing Date
2017-10-27
Accepted
2017-10-27 18:15:16
Documents
1
Period of Report
2017-10-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT bamforth_frm4.html 4  
1 OWNERSHIP DOCUMENT bamforth_frm4.xml 4 13523
  Complete submission text file 0001683168-17-002766.txt   15033
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 KENDALL ST. CAMBRIDGE MA 02142
Business Address
Bamforth Mark R (Reporting) CIK: 0001435745 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32839 | Film No.: 171160430